Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2005-11-2
pubmed:abstractText
This prospective study was undertaken to address the capacity of positron emission tomography (PET) with 2-[18F]fluoro-2-deoxy-D-glucose (18F-FDG) to determine the primary tumour site of carcinomas with unknown primary site.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0143-3636
pubmed:author
pubmed:issnType
Print
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1059-66
pubmed:meshHeading
pubmed-meshheading:16264351-Adenocarcinoma, pubmed-meshheading:16264351-Adult, pubmed-meshheading:16264351-Aged, pubmed-meshheading:16264351-False Positive Reactions, pubmed-meshheading:16264351-Female, pubmed-meshheading:16264351-Fluorodeoxyglucose F18, pubmed-meshheading:16264351-Humans, pubmed-meshheading:16264351-Male, pubmed-meshheading:16264351-Middle Aged, pubmed-meshheading:16264351-Neoplasm Metastasis, pubmed-meshheading:16264351-Neoplasms, pubmed-meshheading:16264351-Neoplasms, Unknown Primary, pubmed-meshheading:16264351-Positron-Emission Tomography, pubmed-meshheading:16264351-Prospective Studies, pubmed-meshheading:16264351-Time Factors, pubmed-meshheading:16264351-Tomography, X-Ray Computed, pubmed-meshheading:16264351-Treatment Outcome, pubmed-meshheading:16264351-Whole-Body Counting
pubmed:year
2005
pubmed:articleTitle
FDG PET in patients with cancer of an unknown primary.
pubmed:affiliation
European Association for Research in Oncology, Department of Medical Oncology, Henri Mondor Hospital, Assistance Publique - Hopitaux de Paris, Lille, France. h-gauthier@o-lambret.fr
pubmed:publicationType
Journal Article